MSG
FLGT icon

Main Street Group’s Fulgent Genetics FLGT Stock Holding History

Main Street Group’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.05K Hold
100
– – ﹤0.01% 732
2026
Q1 		$1.59K Buy
+100
New +$2.17K ﹤0.01% 750
2025
Q4 		– Sell
-100
Closed -$2.26K – 266
2025
Q3 		$2.26K Hold
100
– – ﹤0.01% 682
2025
Q2 		$1.99K Hold
100
– – ﹤0.01% 645
2025
Q1 		$1.69K Hold
100
– – ﹤0.01% 678
2024
Q4 		$1.85K Hold
100
– – ﹤0.01% 658
2024
Q3 		$2.17K Hold
100
– – ﹤0.01% 660
2024
Q2 		$2K Sell
100
-28
-22% -$585 ﹤0.01% 718
2024
Q1 		$2.79K Hold
128
– – ﹤0.01% 718
2023
Q4 		$3.7K Buy
+128
New +$3.42K ﹤0.01% 1023

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Main Street Group's FLGT Position: Q2 2026 in Review

Main Street Group held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 100 shares worth $2.05K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Main Street Group first reported a position in FLGT in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.7K in Q4 2023. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Main Street Group held 100 shares of Fulgent Genetics worth $2.05K as of Q2 2026.
  • Main Street Group left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #732 holding.
  • Main Street Group first reported a position in Fulgent Genetics in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Fulgent Genetics position peaked at $3.7K in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.